Cargando…
Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy
Anti-angiogenesis therapy and immunotherapy are the first-line therapeutic strategies for various tumor treatments in the clinic, bringing significant advantages for tumor patients. Recent studies have shown that anti-angiogenic therapy can potentiate immunotherapy, with many clinical trials conduct...
Autores principales: | Xiao, Mingshu, Shi, Yueli, Jiang, Sujing, Cao, Mengqing, Chen, Weiyu, Xu, Yun, Xu, Zhiyong, Wang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745116/ https://www.ncbi.nlm.nih.gov/pubmed/36523993 http://dx.doi.org/10.3389/fonc.2022.1039378 |
Ejemplares similares
-
Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022) -
Identification of m7G-Related miRNA Signatures Associated with Prognosis, Oxidative Stress, and Immune Landscape in Lung Adenocarcinoma
por: Jiang, Sujing, et al.
Publicado: (2023) -
PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development
por: Jiang, Xinyuan, et al.
Publicado: (2023) -
Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
por: Fleuren, Emmy D. G., et al.
Publicado: (2023) -
Vascular normalization and immunotherapy: Spawning a virtuous cycle
por: Swamy, Kumara
Publicado: (2022)